NCT07806266Recruiting
EORTC Metastatic Breast Cancer Module Development
The European Organisation for Research and Treatment of Cancer: Module Development for Metastatic Breast Cancer (Phase I-IIIa/b)
Source: ClinicalTrials.gov · Last updated 8 Sept 2026
Brief summary (registry, in English)
The overall aim of this project is to help improve the Health Related Quality of Life (HRQOL) of metastatic breast cancer (MBC) patients. There is currently an urgent and unmet need for specific tools to aid in the evaluation of HRQOL in MBC and this project aims to address these needs by developing a comprehensive EORTC questionnaire for assessing the HRQOL of this group. The new module will be used in conjunction with EORTC QLQ-C30 and will provide better measurement of the quality of life issues experienced by women with MBC. Interviews will be conducted with patients from several centres across Europe, guiding the development process in a patient centred way.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 568 (estimated)
- First submitted
- 2 Sept 2026
- Start date
- 1 May 2020
- Primary completion date
- 31 Aug 2028
- Lead sponsor
- University of Leeds
- Diseases
- Metastatic breast cancer
- NCT number
- NCT07806266
What you commit to
- Study type: Observational
- Planned participants: 568
- From 1 May 2020 to the primary completion date, 31 Aug 2028
- 22 sites in 14 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients previously involved in Phase I.
Other illness
- Patients diagnosed with early stage breast cancer.
- Patients with any psychiatric condition or cognitive impairment, as determined by the treating physician, that would hamper participation in interviews.
Who the study is looking for
- Adult females aged 18 years or over.
- Have a diagnosis of MBC (Breast cancer that has spread to another part of the body), including de novo MBC patients. Patients with brain metastases will be included, providing there is no associated major cognitive impairment.
- Have received (patients under observation) or currently receiving treatment for MBC, including chemotherapy, hormone therapy, targeted agents (anti-HER2, CDK4/6 inhibitors, mTOR/PIK3CA inhibitors, PARP inhibitors, immune therapy), radiotherapy and combinations.
- Conversant in the language of questionnaire administration.
- Have the capacity to give informed consent.
Age in the registry: 18 years to - · Sex: Female
Sites (22)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ghent university hospital Coordinator of this site? Confirm its status | Ghent | Belgium | Not yet recruiting |
| Centre Hospitalier de l'Université de Montréal Coordinator of this site? Confirm its status | Montreal | Canada | Not yet recruiting |
| Odette Cancer Center - Sunnybrook Health Sciences Center Coordinator of this site? Confirm its status | Toronto | Canada | Recruiting |
| Charité - Universitätsmedizin Coordinator of this site? Confirm its status | Berlin | Germany | Not yet recruiting |
| Helios University Hospital Coordinator of this site? Confirm its status | Wuppertal | Germany | Recruiting |
| Royal Navarre Hospital Coordinator of this site? Confirm its status | Pamplona | Spain | Recruiting |
| Centre Hospitalier Lyon Sud Coordinator of this site? Confirm its status | Lyon | France | Recruiting |
| University Hospital of Nimes Coordinator of this site? Confirm its status | Nîmes | France | Not yet recruiting |
| Centre Hospitalier Universitaire de Saint Etienne Coordinator of this site? Confirm its status | Saint-Etienne | France | Not yet recruiting |
| St James University Hospital Coordinator of this site? Confirm its status | Leeds | United Kingdom | Recruiting |
| Mount Vernon Cancer Centre Coordinator of this site? Confirm its status | Rickmansworth | United Kingdom | Recruiting |
| Tata Memorial Hospital Coordinator of this site? Confirm its status | Mumbai | India | Not yet recruiting |
| Istituto Nazionale Tumori Coordinator of this site? Confirm its status | Naples | Italy | Recruiting |
| Veneto Institute of Oncology Coordinator of this site? Confirm its status | Padova | Italy | Not yet recruiting |
| King Hussein Cancer Center Coordinator of this site? Confirm its status | Amman | Jordan | Recruiting |
| Kansai Medical University Hospital Coordinator of this site? Confirm its status | Osaka | Japan | Recruiting |
| National Centre for Global Health and Medicine Coordinator of this site? Confirm its status | Tokyo | Japan | Recruiting |
| National Cancer Centre Hospital Coordinator of this site? Confirm its status | Tokyo | Japan | Recruiting |
| NKI-AVL Amsterdam Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Recruiting |
| Maria Sklodowska-Curie - National Research Institute of Oncology Coordinator of this site? Confirm its status | Warsaw | Poland | Not yet recruiting |
| Champalimaud Clinical Centre Coordinator of this site? Confirm its status | Lisbon | Portugal | Not yet recruiting |
| Comenius University and National Cancer Institute Coordinator of this site? Confirm its status | Bratislava | Slovakia | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.